Isabel Fernandez - Atrys Health Chief Executive Officer
| ATRY Stock | EUR 2.87 0.05 1.77% |
CEO
Ms. Isabel Lozano Fernandez serves as Atrys Health, S.A. She has large experience in managing biotechnology and oncology companies, both national and international. She was CEO of PharmaMar and Chief Financial Officer of the Grupo Zeltia for five years. She began her career in management positions in several capital venture groups and in the Arthur Andersen Audit division. since 2016.
| Tenure | 8 years |
| Phone | 34 91 781 94 65 |
| Web | https://www.atryshealth.com |
Atrys Health Management Efficiency
Atrys Health's management efficiency ratios could be used to measure how well Atrys Health manages its routine affairs as well as how well it operates its assets and liabilities.Management Performance
| Return On Equity | -0.0723 | |||
| Return On Asset | 0.0022 |
Atrys Health SL Leadership Team
Elected by the shareholders, the Atrys Health's board of directors comprises two types of representatives: Atrys Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Atrys. The board's role is to monitor Atrys Health's management team and ensure that shareholders' interests are well served. Atrys Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Atrys Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Santiago Sanahuja, Executive Chairman of the Board | ||
| Helena VidalFolch, Head Communication | ||
| Gabriela Camunas, G Counsel | ||
| Carlos CordonCardo, Scientific Vice President | ||
| Anna Valero, Diagnostics Director | ||
| Encarna Vega, Adm Director | ||
| Maria Marin, Head Relations | ||
| Isabel Fernandez, Chief Executive Officer | ||
| Carlo Greco, Vice President of Medical Radiotherapy | ||
| Victor Rumayor, R&D Director | ||
| Jose Ginesta, Chief Financial Officer | ||
| Zvi Fuchs, Founder VP | ||
| Eduardo Dussel, Director of Teleradiology | ||
| Carlos Girn, Chief Officer |
Atrys Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Atrys Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0723 | |||
| Return On Asset | 0.0022 | |||
| Profit Margin | (0.13) % | |||
| Operating Margin | 0.01 % | |||
| Current Valuation | 647.57 M | |||
| Shares Outstanding | 75.89 M | |||
| Shares Owned By Insiders | 78.47 % | |||
| Shares Owned By Institutions | 11.00 % | |||
| Price To Book | 1.28 X | |||
| Price To Sales | 2.47 X |
Pair Trading with Atrys Health
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Atrys Health position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Atrys Health will appreciate offsetting losses from the drop in the long position's value.Moving together with Atrys Stock
| 0.71 | BST | Biotechnology Assets | PairCorr |
Moving against Atrys Stock
| 0.71 | CABK | Caixabank SA | PairCorr |
The ability to find closely correlated positions to Atrys Health could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Atrys Health when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Atrys Health - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Atrys Health SL to buy it.
The correlation of Atrys Health is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Atrys Health moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Atrys Health SL moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Atrys Health can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Atrys Health SL. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Complementary Tools for Atrys Stock analysis
When running Atrys Health's price analysis, check to measure Atrys Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atrys Health is operating at the current time. Most of Atrys Health's value examination focuses on studying past and present price action to predict the probability of Atrys Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atrys Health's price. Additionally, you may evaluate how the addition of Atrys Health to your portfolios can decrease your overall portfolio volatility.
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |